Oxidative theory of atherosclerosis and antioxidants

Biochimie

Volumn 125, Issue , 2016, Pages 281-296

  Salvayre, R ^a,b,c   Negre Salvayre, A ^a   Camare C ^a,b,c  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU RANGUEIL   (France)

Author keywords

Antioxidant; Atherosclerosis; Free radicals; Mediterranean diet; Oxidized LDL; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; FREE RADICAL; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR;

ARTERIOSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROMATOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL DAMAGE; CELL MIGRATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FOAM CELL; HUMAN; LIPID PEROXIDATION; MEDITERRANEAN DIET; MONOCYTE; OXIDATIVE STRESS; SMOOTH MUSCLE CELL; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, CARDIOVASCULAR; OXIDATION-REDUCTION;

EID: 84952939010     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.12.014     Document Type: Article

References (207)

1. J.P. Strong, H.C. McGill Jr., C. Tejada, and R.L. Homan The natural history of atherosclerosis; comparison of the early aortic lesions in New Orleans, Guatemala, and Costa Rica Am. J. Pathol. 34 1958 731 744
2. H.C. McGill, and J.P. Strong The geographic pathology of atherosclerosis Ann. N. Y. Acad. Sci. 149 1968 923 927
3. J. Czermak Description and microscopic findings of two Egyptian mummies Meet. Acad. Sci. 9 1852 27 69
4. M.A. Ruffer On arterial lesions found in Egyptian mummies (1580 bc-535 ad) J. Pathol. Bacteriol. 16 1911 453 462
5. H. Allam, R.C. Thompson, L.S. Wann, M.L. Miyamoto, and G.S. Thomas Computed tomographic assessment of atherosclerosis in ancient Egyptian mummies JAMA 302 2009 2091 2094
6. H.C. Stary Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries Basic Res. Cardiol. 89 Suppl. 1 1994 17 32
7. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
8. V. Fuster, A. Lewis Conner Memorial Lecture Mechanisms leading to myocardial infarction: insights from studies of vascular biology Circulation 90 1994 2126 2146
9. C. Napoli, F.P. D'Armiento, F.P. Mancini, A. Postiglione, J.L. Witztum, G. Palumbo, and W. Palinski Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions J. Clin. Invest. 100 1997 2680 2690
10. H.C. McGill Jr., C.A. McMahan, E.E. Herderick, G.T. Malcom, R.E. Tracy, and J.P. Strong Origin of atherosclerosis in childhood and adolescence Am. J. Clin. Nutr. 72 5 Suppl. 2000 Nov 1307S 1315S
11. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
12. P. Libby, and P. Theroux Pathophysiology of coronary artery disease Circulation 111 2005 3481 3488
13. E. Falk, M. Nakano, J.F. Bentzon, A.V. Finn, and R. Virmani Update on acute coronary syndromes: the pathologists' view Eur. Heart J. 34 2013 719 728
14. J. Cottet, and M. Lenoir Two thousand years of historical study on the words atheroma, atheromatosis, atherosclerosis, arteriosclerosis Bull. Acad. Natl. Med. 176 1992 1385 1390
15. A. von Haller Opuscula Pathologica 1755 Bousquet et soc Lausanne 124 128
16. J. Hogson Engraving Intended to Illustrate Some of the Diseases of the Arteries 1815 T. Underwood London 5
17. H. Lebert Traité d'anatomie pathologique générale et spéciale 1857 Atlas Baillère, Paris
18. e ed. 1868 336 Baillère, Paris
19. J.G.C.F.M. Lobstein Traités D'anatomie Pathologique 1833 FG. Levrault Paris 550 553
20. F. Marchand Über arteriosklerose (athero-sklerose) Verh. Kongr. Inn. Med. 21 1904 23 59
21. D. Steinberg Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I J. Lipid Res. 45 2004 1583 1593
22. M.E. Chevreul Recherches chimiques sur les corps gras d'origine animale (Chapter 9) 1823 de la cholestérine Levrault, Paris pp.153 160
23. J. Vogel The Pathological Anatomy of the Human Body first ed. 1847 Lea and Blanchard Philadelphia
24. A. Ignatowski Influence de la nourriture animale sur l'organisme des lapins Arch. Med. Exp. Anat. Pathol. 20 1908 1 20
25. G. Lemoine Du role de la cholesterine dans le développement de l'artériosclérose et de l'athérome 1911 Vigot frères Paris
26. N. Anitchkow, and S. Chalatow Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehlung einiger pathologischer Prozesse Zentrbl. Allg. Pathol. Pathol. Anat. 24 1913 1 9
27. N.W. Wesselkin Über die Ablagerung von fettartigen Stoffen in den Organen Virchows Arch. Pathol. Anat. Physiol. Klin. Med 212 1913 225 235
28. G. Lemoine Sur la presence de depots de cholesterine dans les tuniques arterielles sclero-atheromateuses Compt. Rend. Acad. Sci. Paris 151 1910 1079 1080
29. A. Windaus Über der Gehalt normaler und atheromatoser Aorten and Cholesterol und Cholesterinester Hoppe Seyler's Z. Physiol. Chem. 67 1910 174 182
30. D. Kritchevsky Dietary proteins, cholesterol and atherosclerosis. A review of the early history J. Nutr. 125 1995 589S 593S
31. M.A. Macheboeuf Recherches sur les phosphoaminolipides et les sterides du serum et du plasma sanguins Bull. Soc. Chim. Biol. 11 1929 268 293
32. G. Blix, A. Tiselius, and H. Svensson Lipids and polysaccharides in electrophoretically separated blood serum proteins J. Biol. Chem. 137 1941 485 494
33. K.O. Pedersen On a LDL appearing in normal human plasma J. Phys. Colloid Chem. 51 1945 156 163
34. E.J. Cohn, L.E. Strong, W.L. Hughes Jr., D.J. Mulford, J.N. Ashworth, M. Melin, and H.L. Taylor Preparation and properties of serum and plasma lipoproteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids J. Am. Chem. Soc. 68 1946 459 475
35. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
36. D.S. Fredrickson, R.I. Levy, and R.S. Lees Fat transport in lipoproteins - an integrated approach to mechanisms and disorders N. Engl. J. Med. 276 1967 1967 34 42
37. G. Lehzen, and K. Knauss Über Xanthoma multiplex planum, tuberosurn, mollusciforme Arch. Pathol. Anat. Physiol. 116 1989 85 86
38. F. Pinkus, and L. Pick Zur Struktur und Genese der symptomatischen Xanthome Deutsch. Med. Wochenschr. 34 1908 1426 1430
39. C. Muller Angina pectoris in hereditary xanthornatosis Arch. Htem. Med. 64 1939 675 678
40. C.F. Wilkinson, E.A. Hand, and M.T. Fliegelman Essential familial hypercholesterolemia Ann. Intern. Med. 29 1948 671 686
41. D. Adlersberg Hypercholesterolemia with predisposition to atherosclerosis: an inborn error of lipid metabolism Am. J. Med. 11 1951 600 607
42. J.W. Gofman, and F. Lindgren The role of lipids and lipoproteins in atherosclerosis Science 111 1950 1950 166 171
43. W.B. Kannel, T.R. Dawber, A. Kagan, N. Revotskie, and J. Stokes 3rd Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study Ann. Intern. Med. 55 1961 33 50
44. N.D. Wong Epidemiological studies of CHD and the evolution of preventive cardiology Nat. Rev. Cardiol. 11 2014 276 289
45. J.L. Goldstein, and M.S. Brown The LDL pathway and its relation to atherosclerosis Annu. Rev. Biochem. 46 1977 897 930
46. M.S. Brown, and J.L. Goldstein Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis Annu. Rev. Biochem. 52 1983 223 261
47. J.L. Goldstein, and M.S. Brown A century of cholesterol and coronaries: from plaques to genes to statins Cell 161 2015 161 172
48. J. Weiss Biological action of radiations Nature 157 1946 584
49. T. Alpert Hydrogen peroxide and the indirect effect of ionizing radiations Nature 162 1948 615
50. W.A. Waters The Chemistry of Free Radicals 1946 Oxford University Press London
51. P.J. Mann, and J.H. Quastel Toxic effects of oxygen and of hydrogen peroxide on brain metabolism Biochem. J. 40 1946 139 144
52. J.A. Butler, and K.A. Smith Degradation of deoxyribonucleic acid by free radicals Nature 165 1950 847 848
53. D. Harman Aging: a theory based on free radical and radiation chemistry J. Gerontol. 11 1956 298 300
54. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine fourth ed. 2007 Clarendon Press Oxford
55. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
56. J.W. Baynes, and S.R. Thorpe Glycoxidation and lipoxidation in atherogenesis Free Radic. Biol. Med. 28 2000 1708 1716
57. A. Negre-Salvayre, C. Coatrieux, C. Ingueneau, and R. Salvayre Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors Br. J. Pharmacol. 153 2008 6 20
58. G. Vistoli, D. De Maddis, A. Cipak, N. Zarkovic, M. Carini, and G. Aldini Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation Free Radic. Res. 47 Suppl. 1 2013 3 27
59. A. Negre-Salvayre, N. Auge, V. Ayala, H. Basaga, J. Boada, R. Brenke, S. Chapple, G. Cohen, J. Feher, T. Grune, G. Lengyel, G.E. Mann, R. Pamplona, G. Poli, M. Portero-Otin, Y. Riahi, R. Salvayre, S. Sasson, J. Serrano, O. Shamni, W. Siems, R.C. Siow, I. Wiswedel, K. Zarkovic, and N. Zarkovic Pathological aspects of lipid peroxidation Free Radic. Res. 44 2010 1125 1171
60. G. Jürgens, J. Lang, and H. Esterbauer Modification of human LDL by the lipid peroxidation product 4-hydroxynonenal Biochim. Biophys. Acta 875 1986 103 114
61. K. Uchida Redox-derived damage-associated molecular patterns: ligand function of lipid peroxidation adducts Redox Biol. 1 2013 94 96
62. A. Höhn, and T. Grune Lipofuscin: formation, effects and role of macroautophagy Redox Biol. 1 2013 140 144
63. A.M. Papenheimer, and J. Victor 'Ceroid' pigment in human tissues Am. J. Pathol. 22 1946 395 400
64. J. Glavind, and S. Hartmann The occurrence of peroxidized lipids in atheromatous human aortas Experientia 7 1951 464
65. M. Iwakami Peroxides as a factor of atherosclerosis Nagoya J. Med. Sci. 28 1965 50 66
66. V.Z. Lankin, A.K. Tikhaze, and N.V. Kotelevtseva Lipid peroxides and arteriosclerosis Kardiologiia 16 1976 23 30
67. T. Henriksen, E.M. Mahoney, and D. Steinberg Enhanced macrophage degradation of LDL previously incubated with cultured endothelial cells: recognition by receptors for acetylated LDL Proc. Natl. Acad. Sci. U. S. A. 78 1981 6499 6503
68. J.R. Hessler, D.W. Morel, L.J. Lewis, and G.M. Chisolm Lipoprotein oxidation and lipoprotein-induced cytotoxicity Arteriosclerosis 3 1983 215 222
69. H. Esterbauer, M. Dieber-Rotheneder, G. Waeg, G. Striegl, and G. Jürgens Biochemical, structural, and functional properties of oxidized LDL Chem. Res. Toxicol. 3 1990 77 92
70. G. Poli, B. Sottero, S. Gargiulo, and G. Leonarduzzi Cholesterol oxidation products in the vascular remodeling due to atherosclerosis Mol. Asp. Med. 30 2009 180 189
71. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478
72. J.W. Heinecke, H. Rosen, and A. Chait Iron and copper promote modification of LDL by human arterial smooth muscle cells in culture J. Clin. Invest. 84 1984 1890 1894
73. D.W. Morel, P.E. DiCorleto, and G.M. Chisolm Endothelial and smooth muscle cells alter LDL in vitro by free radical oxidation Arteriosclerosis 4 1984 357 364
74. C.P. Sparrow, S. Parthasarathy, and D. Steinberg Enzymatic modification of LDL by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification J. Lipid Res. 29 1988 745 753
75. J.A. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherogenesis Free Radic. Biol. Med. 20 1996 707 727
76. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of LDL that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
77. M.C. Chia The role of adhesion molecules in atherosclerosis Crit. Rev. Clin. Lab. Sci. 35 1998 573 602
78. J. Frostegård, J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund Oxidized LDL induces differentiation and adhesion of human monocytes and the monocytic cell line U937 Proc. Natl. Acad. Sci. U. S. A. 87 1990 904 908
79. T.B. Rajavashisth, A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, A.M. Fogelman, and A.J. Lusis Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified LDL Nature 344 1990 254 257
80. B. Hennig, and C.K. Chow Lipid peroxidation and endothelial cell injury: implications in atherosclerosis Free Radic. Biol. Med. 4 1988 99 106
81. A.M. Fogelman, I. Shechter, J. Seager, M. Hokom, J.S. Child, and P.A. Edwards Malondialdehyde alteration of LDL leads to cholesteryl ester accumulation in human monocyte-macrophages Proc. Natl. Acad. Sci. U. S. A. 77 1980 2214 2218
82. H.F. Hoff, J. O'Neil, G.M. Chisolm 3rd, T.B. Cole, O. Quehenberger, H. Esterbauer, and G. Jürgens Modification of LDL with 4-hydroxynonenal induces uptake by macrophages Arteriosclerosis 9 1989 538 549
83. M.E. Haberland, D. Fong, and L. Cheng Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits Science 241 1988 215 218
84. G. Jürgens, Q. Chen, H. Esterbauer, S. Mair, G. Ledinski, and H.P. Dinges Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a) Arterioscler. Thromb. 13 1993 1689 1699
85. T. Henriksen, S.A. Evensen, and B. Carlander Injury to human endothelial cells in culture induced by LDL Scand. J. Clin. Lab. Invest. 39 1979 361 368
86. J.R. Hessler, A.L. Robertson Jr., and G.M. Chisolm 3rd LDL-induced cytotoxicity and its inhibition by HDL in human smooth muscle and endothelial cells in culture Atherosclerosis 32 1979 213 229
87. A. Kontush, L. Chancharme, I. Escargueil-Blanc, P. Therond, R. Salvayre, A. Nègre-Salvayre, and M.J. Chapman Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides FASEB J. 17 2003 88 90
88. H. Imai, N.T. Werthessen, V. Subramayam, P.W. Lequesne, A.H. Soloway, and M. Kanisawa Angiotoxicity of oxygenated sterols and possible precursors Science 207 1980 651 653
89. M.D. Coffey, R.A. Cole, S.M. Colles, and G.M. Chisolm In vitro cell injury by oxidized LDL involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals J. Clin. Invest. 96 1995 1866 1873
90. Y. Riahi, N. Kaiser, G. Cohen, I. Abd-Elrahman, G. Blum, O.M. Shapira, T. Koler, M. Simionescu, A.V. Sima, N. Zarkovic, K. Zarkovic, M. Orioli, G. Aldini, E. Cerasi, G. Leibowitz, and S. Sasson Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner J. Cell. Mol. Med. 19 2015 1887 1899
91. A. Negre-Salvayre, M. Lopez, T. Levade, M.T. Pieraggi, N. Dousset, L. Douste-Blazy, and R. Salvayre UV-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of UV-treated LDL on lymphoid cell lines Biochim. Biophys. Acta 1045 1990 224 232
92. L. Cominacini, A.F. Pasini, U. Garbin, A. Davoli, M.L. Tosetti, M. Campagnola, A. Rigoni, A.M. Pastorino, V. Lo Cascio, and T. Sawamura Oxidized LDL binding to LOX-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species J. Biol. Chem. 275 2000 12633 12638
93. H.N. Hodis, D.M. Kramsch, P. Avogaro, G. Bittolo-Bon, G. Cazzolato, J. Hwang, H. Peterson, and A. Sevanian Biochemical and cytotoxic characteristics of an in vivo circulating oxidized LDL J. Lipid Res. 35 1994 669 677
94. K. Kosugi, D.W. Morel, P.E. DiCorleto, and G.M. Chisolm Toxicity of oxidized LDL to cultured fibroblasts is selective for S phase of the cell cycle J. Cell. Physiol. 130 1987 311 320
95. A. Nègre-Salvayre, G. Fitoussi, V. Réaud, M.T. Pieraggi, J.C. Thiers, and R. Salvayre A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells FEBS Lett. 299 1992 60 65
96. I. Escargueil-Blanc, R. Salvayre, and A. Nègre-Salvayre Necrosis and apoptosis induced by oxidized LDL occur through two calcium-dependent pathways in lymphoblastoid cells FASEB J. 8 1994 1075 1080
97. C. Ingueneau, U.D. Huynh, B. Marcheix, A. Athias, P. Gambert, A. Nègre-Salvayre, R. Salvayre, and C. Vindis TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells J. Cell. Mol. Med. 13 8B 2009 1620 1631
98. M.I. Pörn-Ares, T.C. Saido, T. Andersson, and M.P. Ares Oxidized LDL induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 Biochem. J. 374 2003 403 411
99. C. Vindis, M. Elbaz, I. Escargueil-Blanc, N. Augé, A. Heniquez, J.C. Thiers, A. Nègre-Salvayre, and R. Salvayre Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis Arterioscler. Thromb. Vasc. Biol. 25 2005 639 645
100. O. Meilhac, I. Escargueil-Blanc, J.C. Thiers, R. Salvayre, and A. Negre-Salvayre Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized LDL FASEB J. 13 1999 485 494
101. S.R. Panini, and M.S. Sinensky Mechanisms of oxysterol-induced apoptosis Curr. Opin. Lipidol. 12 2001 2001 529 533
102. S.M. Colles, J.M. Maxson, S.G. Carlson, and G.M. Chisolm Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols Trends Cardiovasc. Med. 11 2001 131 138
103. M. Sata, and K. Walsh Oxidized LDL activates fas-mediated endothelial cell apoptosis J. Clin. Investig. 102 1998 1682 1689
104. R. Salvayre, N. Augé, H. Benoist, and A. Negre-Salvayre Oxidized low-density lipoprotein-induced apoptosis Biochim. Biophys. Acta 1585 2002 213 221
105. A. Tedgui, and Z. Mallat Apoptosis as a determinant of atherothrombosis Thromb. Haemost. 86 2001 420 426
106. F. Liao, A. Andalibi, J.H. Qiao, H. Allayee, A.M. Fogelman, and A.J. Lusis Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice J. Clin. Investig. 94 1994 877 884
107. S. Lee, K.G. Birukov, C.E. Romanoski, J.R. Springstead, A.J. Lusis, and J.A. Berliner Role of phospholipid oxidation products in atherosclerosis Circ. Res. 111 2012 778 799
108. F. Robbesyn, R. Salvayre, and A. Negre-Salvayre Dual role of oxidized LDL on the NF-kappaB signaling pathway Free Radic. Res. 38 2004 541 551
109. C. Mazière, and J.C. Mazière Activation of transcription factors and gene expression by oxidized LDL Free Radic. Biol. Med. 46 2009 127 137
110. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
111. W. Palinski, M.E. Rosenfeld, S. Ylä-Herttuala, G.C. Gurtner, S.S. Socher, S.W. Butler, S. Parthasarathy, T.E. Carew, D. Steinberg, and J.L. Witztum LDL undergoes oxidative modification in vivo Proc. Natl. Acad. Sci. U. S. A. 86 1989 1372 1376
112. M. Kumano-Kuramochi, Y. Shimozu, C. Wakita, M. Ohnishi-Kameyama, T. Shibata, S. Matsunaga, Y. Takano-Ishikawa, J. Watanabe, M. Goto, Q. Xie, S. Komba, K. Uchida, and S. Machida Identification of 4-HNE-histidine adducts that serve as ligands for human LOX-1 Biochem. J. 442 2012 171 180
113. R. Wildburger, S. Borović, N. Zarković, and F. Tatzber Post-traumatic dynamic changes in the antibody titer against oxidized LDL Wien. Klin. Wochenschr. 112 2000 798 803
114. M.F. Lopes-Virella, and G. Virella Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis J. Atheroscler. Thromb. 20 2013 743 754
115. A. Dandapat, C. Hu, L. Sun, and J.L. Mehta Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway Arterioscler. Thromb. Vasc. Biol. 27 2007 2435-2342
116. C. Camaré, M. Trayssac, B. Garmy-Susini, E. Mucher, R. Sabbadini, R. Salvayre, and A. Negre-Salvayre Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody Br. J. Pharmacol. 172 2015 106 118
117. F.Y. Lin, N.W. Tsao, C.M. Shih, Y.W. Lin, J.S. Yeh, J.W. Chen, H. Nakagami, R. Morishita, T. Sawamura, and C.Y. Huang The biphasic effects of oxidized-LDL on the vasculogenic function of endothelial progenitor cells PLoS One 10 2015 e0123971
118. P.R. Moreno, K.R. Purushothaman, M. Sirol, A.P. Levy, and V. Fuster Neovascularization in human atherosclerosis Circulation 113 2006 2245 2252
119. R. Khurana, M. Simons, J.F. Martin, and I.C. Zachary Role of angiogenesis in cardiovascular disease: a critical appraisal Circulation 112 2005 1813 1824
120. I. Autio, O. Jaakkola, T. Solakivi, and T. Nikkari Oxidized LDL is chemotactic for arterial smooth muscle cells in culture FEBS Lett. 277 1990 247 249
121. S. Chatterjee Role of oxidized human plasma LDL in atherosclerosis: effects on smooth muscle cell proliferation Mol. Cell. Biochem. 111 1992 143 147
122. N. Augé, M.T. Pieraggi, J.C. Thiers, A. Nègre-Salvayre, and R. Salvayre Proliferative and cytotoxic effects of mildly oxidized LDL on vascular smooth-muscle cells Biochem. J. 309 1995 1015 1020
123. A. Stiko-Rahm, A. Hultgårdh-Nilsson, J. Regnström, A. Hamsten, and J. Nilsson Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells Arterioscler. Thromb. 12 1992 1099 1109
124. I. Escargueil-Blanc, R. Salvayre, N. Vacaresse, G. Jürgens, B. Darblade, J.F. Arnal, S. Parthasarathy, and A. Nègre-Salvayre Mildly oxidized LDL induces activation of PDGF beta-receptor pathway Circulation 104 2001 1814 1821
125. C. Vindis, I. Escargueil-Blanc, M. Elbaz, B. Marcheix, M.H. Grazide, K. Uchida, R. Salvayre, and A. Nègre-Salvayre Desensitization of PDGF receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers Circ. Res. 98 2006 785 792
126. A. Negre-Salvayre, O. Vieira, I. Escargueil-Blanc, and R. Salvayre Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity Mol. Asp. Med. 24 2003 251 261
127. V. Natarajan, W.M. Scribner, C.M. Hart, and S. Parthasarathy Oxidized LDL-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis J. Lipid Res. 36 1995 2005 2016
128. S. Chatterjee, and N. Ghosh Oxidized LDL stimulates aortic smooth muscle cell proliferation Glycobiology 6 1996 303 311
129. N. Augé, N. Andrieu, A. Nègre-Salvayre, J.C. Thiers, T. Levade, and R. Salvayre The sphingomyelin-ceramide signaling pathway is involved in oxidized LDL-induced cell proliferation J. Biol. Chem. 271 1996 19251 19255
130. N. Augé, A. Nègre-Salvayre, R. Salvayre, and T. Levade Sphingomyelin metabolites in vascular cell signaling and atherogenesis Prog. Lipid Res. 39 2000 207 229
131. S. Jimi, K. Saku, N. Uesugi, N. Sakata, and S. Takebayashi Oxidized LDL stimulates collagen production in cultured arterial smooth muscle cells Atherosclerosis 116 1995 15 26
132. Y. Huang, M. Mironova, and M.F. Lopes-Virella Oxidized LDL stimulates MMP1 expression in human vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 19 1999 2640 2647
133. X.P. Xu, S.R. Meisel, J.M. Ong, S. Kaul, B. Cercek, T.B. Rajavashisth, B. Sharifi, and P.K. Shah Oxidized LDL regulates MMP-9 and its tissue inhibitor in human monocyte-derived macrophages Circulation 99 1999 993 998
134. A.C. Newby, K.M. Southgate, and M. Davies Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis Basic Res. Cardiol. 89 Suppl. 1 1994 59 70
135. S.J. George TIPs and MMPs in atherosclerosis Curr. Opin. Lipidol. 9 1998 413 423
136. N. Augé, F. Maupas-Schwalm, M. Elbaz, J.C. Thiers, A. Waysbort, S. Itohara, H.W. Krell, R. Salvayre, and A. Nègre-Salvayre Role for MMP2 in oxidized LDL-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation Circulation 110 2004 571 578
137. K. Zarkovic, P. Larroque-Cardoso, M. Pucelle, R. Salvayre, G. Waeg, A. Nègre-Salvayre, and N. Zarkovic Elastin aging and lipid oxidation products in human aorta Redox Biol. 4 2015 109 117
138. T. Thim, M.K. Hagensen, J.F. Bentzon, and E. Falk From vulnerable plaque to atherothrombosis J. Intern. Med. 263 2008 506 516
139. L. Badimon, R.F. Storey, and G. Vilahur Update on lipids, inflammation and atherothrombosis Thromb. Haemost. 105 Suppl. 1 2011 S34 S42
140. J.W. Zmijewski, D.R. Moellering, C. Le Goffe, A. Landar, A. Ramachandran, and V.M. Darley-Usmar Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells Am. J. Physiol. Heart Circ. Physiol. 289 2005 H852 H861
141. C. Napoli, F. de Nigris, and W. Palinski Multiple role of reactive oxygen species in the arterial wall J. Cell. Biochem. 82 2001 674 682
142. B. Lassègue, A. San Martín, and K.K. Griendling Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system Circ. Res. 110 2012 1364 1390
143. D. Harrison, K.K. Griendling, U. Landmesser, B. Hornig, and H. Drexler Role of oxidative stress in atherosclerosis Am. J. Cardiol. 91 3A 2003 7A 11A
144. T. Michel, and P.M. Vanhoutte Cellular signaling and NO production Pflugers Arch. 459 2010 807 816
145. A. Szczeklik, and R.J. Gryglewski LDL are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries Artery 7 1980 488 495
146. T.A. Drake, K. Hannani, H.H. Fei, S. Lavi, and J.A. Berliner Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells Am. J. Pathol. 138 1991 601 607
147. C.S. Chu, Y.C. Wang, L.S. Lu, B. Walton, H.R. Yilmaz, R.Y. Huang, T. Sawamura, R.A. Dixon, W.T. Lai, C.H. Chen, and J. Lu Electronegative LDL increases CRP expression in vascular endothelial cells through the LOX-1 receptor PLoS One 8 2013 e70533
148. K. Kugiyama, T. Sakamoto, I. Misumi, S. Sugiyama, M. Ohgushi, H. Ogawa, M. Horiguchi, and H. Yasue Transferable lipids in oxidized LDL stimulate plasminogen activator inhibitor-1 and inhibit tPA release from endothelial cells Circ. Res. 73 1993 335 343
149. N.G. Ardlie, M.L. Selley, and L.A. Simons Platelet activation by oxidatively modified LDL Atherosclerosis 76 1989 117 124
150. M. Aviram Modified forms of LDL affect platelet aggregation in vitro Thromb. Res. 53 1989 561 567
151. I. Levitan, S. Volkov, and P.V. Subbaiah Oxidized LDL: diversity, patterns of recognition, and pathophysiology Antioxid. Redox Signal. 13 2010 39 75
152. S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis. An appraisal J. Lipid Res. 40 1999 2143 2157
153. W. Jessup, L. Kritharides, and R. Stocker Lipid oxidation in atherogenesis: an overview Biochem. Soc. Trans. 32 2004 134 138
154. H. Kühn, and V.B. O'Donnell Inflammation and immune regulation by 12/15-lipoxygenases Prog. Lipid Res. 45 2006 334 356
155. P. Libby, P.M. Ridker, and G.K. Hansson Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice J. Am. Coll. Cardiol. 54 2009 2129 2138
156. B. Kalyanaraman Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms Redox Biol. 1 2013 244 257
157. E.M. Hanschmann, J.R. Godoy, C. Berndt, C. Hudemann, and C.H. Lillig Thioredoxins, glutaredoxins, and peroxiredoxins - Molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling Antioxid. Redox Signal. 19 2013 1539 1605
158. Y.S. Ho, J.L. Magnenat, M. Gargano, and J. Cao The nature of antioxidant defense mechanisms: a lesson from transgenic studies Environ. Health Perspect. 106 Suppl. 5 1998 1219 1228
159. S. Parthasarathy, A. Raghavamenon, M.O. Garelnabi, and N. Santanam Oxidized LDL Methods Mol. Biol. 610 2010 403 417
160. S. Parthasarathy, L.G. Fong, M.T. Quinn, and D. Steinberg Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification Eur. Heart J. 11 Suppl. E 1990 83 87
161. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jürgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radic. Biol. Med. 13 1992 341 390
162. L. Mabile, G. Fitoussi, B. Periquet, A. Schmitt, R. Salvayre, and A. Nègre-Salvayre Alpha-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized LDL in cultured endothelial cells Free Radic. Biol. Med. 19 1995 177 187
163. A. Negre-Salvayre, N. Dousset, G. Ferretti, T. Bacchetti, G. Curatola, and R. Salvayre Antioxidant and cytoprotective properties of HDL in vascular cells Free Radic. Biol. Med. 41 2006 1031 1040
164. M. Sanson, C. Ingueneau, C. Vindis, J.C. Thiers, Y. Glock, H. Rousseau, Y. Sawa, Y. Bando, Z. Mallat, R. Salvayre, and A. Nègre-Salvayre Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDL in vascular cells Cell Death Differ. 15 2008 1255 1265
165. R. Faruqi, C. de la Motte, and P.E. DiCorleto Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells J. Clin. Invest. 94 1994 592 600
166. A. Azzi, R. Gysin, P. Kempná, A. Munteanu, Y. Negis, L. Villacorta, T. Visarius, and J.M. Zingg Vitamin E mediates cell signaling and regulation of gene expression Ann. N. Y. Acad. Sci. 1031 2004 86 95
167. M.B. Ruiz-Larrea, A.R. Mohan, G. Paganga, N.J. Miller, G.P. Bolwell, and C.A. Rice-Evans Antioxidant activity of phytoestrogenic isoflavones Free Radic. Res. 26 1997 63 70
168. M.E. Lönn, J.M. Dennis, and R. Stocker Actions of "antioxidants" in the protection against atherosclerosis Free Radic. Biol. Med. 53 2012 863 884
169. T. Fukai, and M. Ushio-Fukai Superoxide dismutases: role in redox signaling, vascular function, and diseases Antioxid. Redox Signal. 15 2011 1583 1606
170. S.M. Tan, A. Sharma, D.Y. Yuen, N. Stefanovic, G. Krippner, G. Mugesh, Z. Chai, and J.B. de Haan T he modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice PLoS One 8 2013 e69193
171. Z. Guo, Q. Ran, L.J. Roberts 2nd, L. Zhou, A. Richardson, C. Sharan, D. Wu, and H. Yang Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice Free Radic. Biol. Med. 44 2008 343 352
172. H. Yang, L.J. Roberts, M.J. Shi, L.C. Zhou, B.R. Ballard, A. Richardson, and Z.M. Guo Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E Circ. Res. 95 2004 1075 1081
173. M.A. Perrella, and S.F. Yet Role of heme oxygenase-1 in cardiovascular function Curr. Pharm. Des. 9 2003 2479 2487
174. J. Kisucka, A.K. Chauhan, I.S. Patten, A. Yesilaltay, C. Neumann, R.A. Van Etten, M. Krieger, and D.D. Wagner Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis Circ. Res. 103 2008 598 605
175. J.G. Park, J.Y. Yoo, S.J. Jeong, J.H. Choi, M.R. Lee, M.N. Lee, J. Hwa Lee, H.C. Kim, H. Jo, D.Y. Yu, S.W. Kang, S.G. Rhee, M.H. Lee, and G.T. Oh Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice Circ. Res. 109 2011 739 749
176. X. Guo, S. Yamada, A. Tanimoto, Y. Ding, K.Y. Wang, S. Shimajiri, Y. Murata, S. Kimura, T. Tasaki, A. Nabeshima, T. Watanabe, K. Kohno, and Y. Sasaguri Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apoE knockout mice Antioxid. Redox Signal. 17 2012 1362 1375
177. X. Wang, S.A. Phelan, C. Petros, E.F. Taylor, G. Ledinski, G. Jürgens, K. Forsman-Semb, and B. Paigen Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis Atherosclerosis 177 2004 61 70
178. D.F. Mahmood, A. Abderrazak, K. El Hadri, T. Simmet, and M. Rouis The thioredoxin system as a therapeutic target in human health and disease Antioxid. Redox Signal. 19 2013 1266 1303
179. H. Zhang, Y. Luo, W. Zhang, Y. He, S. Dai, R. Zhang, Y. Huang, P. Bernatchez, F.J. Giordano, G. Shadel, W.C. Sessa, and W. Min Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions Am. J. Pathol. 170 2007 1108 1120
180. D.A. Zamora, K.P. Downs, S.L. Ullevig, S. Tavakoli, H.S. Kim, M. Qiao, D.R. Greaves, and R. Asmis Glutaredoxin 2a overexpression in macrophages promotes mitochondrial dysfunction but has little or no effect on atherogenesis in LDL-receptor null mice Atherosclerosis 241 2015 69 78
181. A. Negre-Salvayre, C. Hirtz, G. Carrera, R. Cazenave, M. Troly, R. Salvayre, L. Penicaud, and L. Casteilla A role for UCP-2 as a regulator of mitochondrial H2O2 generation Faseb J. 11 1997 809 815
182. J. Blanc, M.C. Alves-Guerra, B. Esposito, S. Rousset, P. Gourdy, D. Ricquier, A. Tedgui, B. Miroux, and Z. Mallat Protective role of UCP-2 in atherosclerosis Circulation 107 2003 388 390
183. H. Wakuda, S. Uchida, M. Ikeda, M. Tabuchi, Y. Akahoshi, K. Shinozuka, and S. Yamada Is hyperuricemia a risk factor for arteriosclerosis? Uric acid and arteriosclerosis in apolipoprotein e-deficient mice Biol. Pharm. Bull. 37 2014 1866 1871
184. E. Krishnan Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout Rheumatology 49 2010 1229 1238
185. M. Rosenblat, R. Coleman, and M. Aviram Increased macrophage glutathione reduces cell-mediated oxidation of LDL and atherosclerosis in apoE-deficient mice Atherosclerosis 163 2002 17 28
186. W.J. Zhang, K.E. Bird, T.S. McMillen, R.C. LeBoeuf, T.M. Hagen, and B. Frei Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apoE-deficient and apoE/LDL-receptor-deficient mice Circulation 117 2008 421 428
187. S.J. Kang, C. Lee, and P. Kruzliak Effects of serum bilirubin on atherosclerotic processes Ann. Med. 46 2014 138 147
188. A.R. Kundur, I. Singh, and A.C. Bulmer Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome? Atherosclerosis 239 2015 73 84
189. F. Tang, M. Lu, S. Zhang, M. Mei, T. Wang, P. Liu, and H. Wang Vitamin E conditionally inhibits atherosclerosis in ApoE knockout mice by anti-oxidation and regulation of vasculature gene expressions Lipids 49 2014 1215 1223
190. M. Meydani, P. Kwan, M. Band, A. Knight, W. Guo, J. Goutis, and J. Ordovas Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet Atherosclerosis 233 2014 196 205
191. Y. Stein, O. Stein, B. Delplanque, J.D. Fesmire, D.M. Lee, and P. Alaupovic Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels Atherosclerosis 75 1989 145 155
192. S.H. Zhang, R.L. Reddick, E. Avdievich, L.K. Surles, R.G. Jones, J.B. Reynolds, S.H. Quarfordt, and N. Maeda Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice J. Clin. Invest. 99 1997 2858 2866
193. J.M. Gaziano Vitamin E and cardiovascular disease: observational studies Ann. N. Y. Acad. Sci. 1031 2004 280 291
194. J.A. Leopold Antioxidants and coronary artery disease: from pathophysiology to preventive therapy Coron. Artery Dis. 26 2015 176 183
195. R.A. Riemersma, D.A. Wood, C.C. Macintyre, R. Elton, K.F. Gey, and M.F. Oliver Low plasma vitamins E and C. Increased risk of angina in Scottish men Ann. N. Y. Acad. Sci. 570 1989 291 295
196. K.F. Gey, and P. Puska Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology Ann. N. Y. Acad. Sci. 570 1989 268 282
197. G. Maiolino, G. Rossitto, P. Caielli, V. Bisogni, G.P. Rossi, and L.A. Calò The role of oxidized LDL in atherosclerosis: the myths and the facts Mediat. Inflamm. 2013 2013 714653
198. P. Knekt, J. Ritz, M.A. Pereira, E.J. O'Reilly, K. Augustsson, G.E. Fraser, U. Goldbourt, B.L. Heitmann, G. Hallmans, S. Liu, P. Pietinen, D. Spiegelman, J. Stevens, J. Virtamo, W.C. Willett, E.B. Rimm, and A. Ascherio Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts Am. J. Clin. Nutr. 80 2004 1508 1520
199. J. Bleys, E.R. Miller 3rd, R. Pastor-Barriuso, L.J. Appel, and E. Guallar Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials Am. J. Clin. Nutr. 84 2006 880 887
200. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu, and E.J. Topol Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials Lancet 361 2003 2017 2023
201. Y. Ye, J. Li, and Z. Yuan Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials PloS One 8 2013 e56803
202. S.K. Myung, W. Ju, B. Cho, S.W. Oh, S.M. Park, B.K. Koo, B.J. Park Korean Meta-Analysis Study Group Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials BMJ 346 2013 f10
203. K. Rees, L. Hartley, C. Day, N. Flowers, A. Clarke, and S. Stranges Selenium supplementation for the primary prevention of cardiovascular disease Cochrane Database Syst. Rev. 1 2013 CD009671
204. F. Sofi, R. Abbate, G.F. Gensini, and A. Casini Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis Am. J. Clin. Nutr. 92 2010 1189 1196
205. K.W. Walton Pathogenetic mechanisms in atherosclerosis Am. J. Cardiol. 35 1975 542 558
206. G. Weber, and G. Camagni Frequency of aortic atherosclerosis in chronic and acute endocarditis; inflammatory genesis of the atherosclerotic process Arch. De Vecchi Anat. Pathol. 14 1950 45 69
207. D. Steinberg, and J.L. Witztum Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105 2002 2107 2111